Skip to search formSkip to main contentSkip to account menu

Saquinavir:MCnc:Pt:Ser/Plas:Qn

Known as: Saquinavir:Mass Concentration:Point in time:Serum/Plasma:Quantitative, Saquinavir [Mass/volume] in Serum or Plasma, Saquinavir:MCnc:Pt:Sor/Plas:Qn 
National Institutes of Health

Related topics

Related topics

4 relations
PlasSaquinavirSerumUnit of Mass Concentration

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.
2007
2007
Acute Hepatitis in a Patient Treated with Saquinavir and Ritonavir : Absence of Cross-Toxicity with Indinavir
  • 2007
  • Corpus ID: 46965535
Protease inhibitors (PI) are a new class of agents with potent antiretrovwal activity. A three-drug regimen consisting of a PI… 
2007
2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.
Our objective was to identify possible differences in protease inhibitor plasma concentrations between and within three protease… 
2005
2005
Once-Daily Regimen of Saquinavir, Ritonavir, Didanosine, and Lamivudine in HIV-Infected Patients With Standard Tuberculosis Therapy (TBQD Study)
Objectives:To assess the efficacy and safety of a once-daily regimen with didanosine, lamivudine, saquinavir, and low-dose… 
2004
2004
Sex‐Related Differences in the Pharmacokinetics of Once‐Daily Saquinavir Soft‐Gelatin Capsules Boosted with Low‐Dose Ritonavir in Patients Infected with Human Immunodeficiency Virus Type 1
Study Objectives. To compare the steady‐state pharmacokinetics and safety of saquinavir soft‐gelatin capsules (SGC) plus low‐dose… 
2001
2001
The Insufficient Suppression of Viral Load by Saquinavir Hard Gel Is Reversible: A Retrospective Cohort Study
Abstract Purpose: To assess the effect of changing antiretroviral therapy in patients initially treated with saquinavir hard gel… 
Review
2000
Review
2000
Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.
UNLABELLED Saquinavir is a potent and highly selective HIV protease inhibitor. Initially formulated as a hard-gel capsule (HGC… 
2000
2000
Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART.
Review
1998
Review
1998
Saquinavir Soft-Gel Capsule Formulation
SummarySynopsisSaquinavir is an HIV protease inhibitor which, formulated as a hard-gel capsule (HGC), was the first drug of its… 
1997
1997
Update on antivirals.
Recent studies are indicating that the standard version of saquinavir is not an appropriate anti-HIV regimen protease inhibitor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)